Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $76,251 - $83,979
-1,050 Reduced 24.04%
3,317 $255,000
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $17,858 - $20,819
-333 Reduced 7.09%
4,367 $272,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $290,977 - $316,874
4,700 New
4,700 $314,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Barr E S & CO Portfolio

Follow Barr E S & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barr E S & CO, based on Form 13F filings with the SEC.

News

Stay updated on Barr E S & CO with notifications on news.